The coronavirus disease 2019 (COVID-19) global pandemic continues to spread worldwide
with approximately 216 million confirmed cases and 4.49 million deaths to date. Intensive …

Even before the onslaught of COVID-19 pandemic could settle, the unprecedented rise in
cases with COVID-19 associated mucormycosis pushed the medical health to the fringe …

Abnormal glucose and lipid metabolism in COVID-19 patients were recently reported with
unclear mechanism. In this study, we retrospectively investigated a cohort of COVID-19 …

Concerns that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the etiological agent of coronavirus disease 2019 (COVID-19), may cause new-onset …

Adiponectin (APN) is an adipokine concerned in the regulation of glucose metabolism,
insulin sensitivity and fatty acid oxidation. APN plays a critical role in viral infections by …

Objective Optimal glucocorticoid-induced hyperglycemia (GCIH) management is unclear.
The COVID-19 pandemic has made this issue more prominent because dexamethasone …

Coronavirus disease 2019 (COVID-19) is well known for its respiratory complications;
however, it can also cause extrapulmonary manifestations, including cardiovascular …

Abstract Purpose of Review Multiple studies report an increased incidence of diabetes
following SARS-CoV-2 infection. Given the potential increased global burden of diabetes …

Background Chronic disease appears connected to obesity. However, evidence suggests
that chronic metabolic diseases are more specifically related to adipose dysfunction rather …

Background and aims We investigate the impact of blood glucose on mortality and hospital
length of stay (HLOS) among COVID-19 patients. Methods Retrospective study of 456 …